Tagalogon, Morito .

HRN: 21-81-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFTRIAXONE 1G (VIAL)
08/18/2022
08/25/2022
IV
2g
Q24H
Cap MR, UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: